Scholar Rock Wins FDA Approval for ISEMBYLD, First Muscle-Targeted Treatment for Spinal Muscular Atrophy Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company focused on developing therapies for rare, severe and…
Strata Mental Health Solutions Awarded Compass Pathways Grant to Develop U.S. Provider Training for COMP360 Strata Mental Health Solutions, an expert-led training and implementation partner focused on preparing clinical networks…
MEDIPAL and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for MPS IIIB MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. (TSE: 4552) announced that the…
Aptar Pharma Transfers Advanced Preservative-Free Production Line to Argentina, Expanding Local Drug Delivery Manufacturing Aptar Pharma, a global provider of drug delivery, dosing, protection technologies and related services, has announced…
Gossamer Bio Completes 1-for-80 Reverse Stock Split to Support Nasdaq Listing Compliance Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on developing and commercializing seralutinib for pulmonary arterial…
Bausch + Lomb Receives European CE Mark for Next-Generation SeeLyra Femtosecond Laser Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health company focused on helping people see better and…
Nutromics Receives FDA Breakthrough Device Designation for Wearable Vancomycin Monitoring Patch Nutromics, a medical technology company developing a wearable lab-on-a-patch™ platform for continuous molecular monitoring, announced that the U.S. Food…
One Biosciences and Institut Curie Secure €3.3 Million France 2030 Funding to Advance Single-Cell Diagnostics for Triple-Negative Breast Cancer One Biosciences, a techbio company spun out of Institut Curie and…
Exegenesis Bio and Modalis Partner to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy Exegenesis Bio and Modalis Therapeutics Corporation (TOKYO: 4883) have entered into a research collaboration and license…
Johnson & Johnson Receives CE Mark for ACUVUE OASYS MAX 2-Week Reusable Contact Lens Johnson & Johnson (NYSE: JNJ) announced that it has received CE Marking for ACUVUE OASYS MAX…
Yarrow Bioscience Launches Underwritten Public Offering to Support Autoimmune Thyroid Disease Pipeline Yarrow Bioscience, Inc., a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, has announced…
Kallisio Expands Patient Access Program for Stentra in Head and Neck Cancer Radiation Therapy Kallisio has announced an expanded patient access program designed to help people preparing for radiation therapy…